Moderna (MRNA) Research & Development: 2018-2025
Historic Research & Development for Moderna (MRNA) over the last 8 years, with Sep 2025 value amounting to $801.0 million.
- Moderna's Research & Development fell 29.55% to $801.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 billion, marking a year-over-year decrease of 27.93%. This contributed to the annual value of $4.5 billion for FY2024, which is 6.23% down from last year.
- According to the latest figures from Q3 2025, Moderna's Research & Development is $801.0 million, which was up 14.43% from $700.0 million recorded in Q2 2025.
- In the past 5 years, Moderna's Research & Development registered a high of $1.4 billion during Q4 2023, and its lowest value of $401.0 million during Q1 2021.
- Its 3-year average for Research & Development is $1.1 billion, with a median of $1.1 billion in 2023.
- In the last 5 years, Moderna's Research & Development spiked by 248.70% in 2021 and then crashed by 42.67% in 2025.
- Over the past 5 years, Moderna's Research & Development (Quarterly) stood at $648.0 million in 2021, then surged by 86.88% to $1.2 billion in 2022, then grew by 16.10% to $1.4 billion in 2023, then fell by 20.20% to $1.1 billion in 2024, then decreased by 29.55% to $801.0 million in 2025.
- Its last three reported values are $801.0 million in Q3 2025, $700.0 million for Q2 2025, and $856.0 million during Q1 2025.